产品
编 号：F238620
分子式：C6H13NO4
分子量：163.17
分子式：C6H13NO4
分子量：163.17
产品类型
规格
价格
是否有货
2mg
393
In-stock
5mg
660
In-stock
10mg
988
In-stock
25mg
1980
In-stock
50mg
2800
In-stock
100mg
3920
In-stock
结构图
CAS No: 19130-96-2
产品详情
生物活性：
1-Deoxynojirimycin (Duvoglustat) is a potent and orally active α-glucosidase inhibitor. 1-Deoxynojirimycin suppresses postprandial blood glucose and is widely used for diabetes mellitus. 1-Deoxynojirimycin possesses antihyperglycemic, anti-obesity, and antiviral features.
体内研究：
1-Deoxynojirimycin (Duvoglustat) (20 -80 mg/kg；iv；每日一次，持续 4 周) 显示抗肥胖作用。1-Deoxynojirimycin 通过激活显著改善胰岛素敏感性 db/db 小鼠骨骼肌胰岛素信号通路 PI3K/AKT。Animal Model:db/db mice
Dosage:20, 40, 80 mg/kg
Administration:Intravenously; daily for four weeks
Result:Significantly reduced body weight, blood glucose and serum insulin levels; Improved glucose tolerance and insulin tolerance.
1-Deoxynojirimycin (Duvoglustat) is a potent and orally active α-glucosidase inhibitor. 1-Deoxynojirimycin suppresses postprandial blood glucose and is widely used for diabetes mellitus. 1-Deoxynojirimycin possesses antihyperglycemic, anti-obesity, and antiviral features.
体内研究：
1-Deoxynojirimycin (Duvoglustat) (20 -80 mg/kg；iv；每日一次，持续 4 周) 显示抗肥胖作用。1-Deoxynojirimycin 通过激活显著改善胰岛素敏感性 db/db 小鼠骨骼肌胰岛素信号通路 PI3K/AKT。Animal Model:db/db mice
Dosage:20, 40, 80 mg/kg
Administration:Intravenously; daily for four weeks
Result:Significantly reduced body weight, blood glucose and serum insulin levels; Improved glucose tolerance and insulin tolerance.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备